Table 3 Composition of CD8-depleted DLIs... | American Society of Hematology

Table 3

Composition of CD8-depleted DLIs

Donor for patient	TNC, × 10³	Total lymphocytes, × 10³	CD19⁺, × 10³	CD3⁻/CD16⁺ CD56⁺, × 10³	CD4⁺/CD25^high, × 10³	CD8⁺, × 10³
2*	2480	1399	127.6	86.7	8.95	1.04
3	1682	1167	37.3	82.6	11.67	0.06
4	4391	2538	563.5	444.2	7.61	3.79
5	2046	1399	191.6	151.0	5.59	0.17
8	2914	1898	327.9	198.9	3.42	1.44
9	2794	1656	407.3	104.3	62.91	0.33
10	4281	1580	171.9	127.0	7.90	0.02
11	2082	1650	341.6	129.7	24.09	0.04
Median	2637	1615	259.8	128.4	8.42	0.25

Donor for patient	TNC, × 10³	Total lymphocytes, × 10³	CD19⁺, × 10³	CD3⁻/CD16⁺ CD56⁺, × 10³	CD4⁺/CD25^high, × 10³	CD8⁺, × 10³
2*	2480	1399	127.6	86.7	8.95	1.04
3	1682	1167	37.3	82.6	11.67	0.06
4	4391	2538	563.5	444.2	7.61	3.79
5	2046	1399	191.6	151.0	5.59	0.17
8	2914	1898	327.9	198.9	3.42	1.44
9	2794	1656	407.3	104.3	62.91	0.33
10	4281	1580	171.9	127.0	7.90	0.02
11	2082	1650	341.6	129.7	24.09	0.04
Median	2637	1615	259.8	128.4	8.42	0.25

Numbers indicate cells per 10⁶ CD4 T cells measured in the CD8-depleted DLI products prior to application. TNC indicates total nucleated cells.

Not administered due to early skin GVHD.